Robin L Hansen

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study
    Paula E Goines
    Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, 451 Health Sciences Dr, Suite 6510, Davis, CA 95616, USA
    Mol Autism 2:13. 2011
  2. pmc Polybrominated diphenyl ethers in relation to autism and developmental delay: a case-control study
    Irva Hertz-Picciotto
    Department of Public Health Sciences, School of Medicine, University of California, MS1C, One Shields Ave, Davis, California, USA
    Environ Health 10:1. 2011
  3. doi request reprint Regression in autism: prevalence and associated factors in the CHARGE Study
    Robin L Hansen
    Medical Investigation of Neurodevelopmental Disorders Institute, University of California, Davis, Sacramento 95817, USA
    Ambul Pediatr 8:25-31. 2008
  4. pmc Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study
    Rebecca J Schmidt
    Department of Public Health Sciences, University of California Davis School of Medicine, Davis, CA 95616 8638, USA
    Am J Clin Nutr 96:80-9. 2012
  5. pmc Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders
    Paula Krakowiak
    Division of Epidemiology, Department of Public Health Sciences, University of California, Davis, California, USA
    Pediatrics 129:e1121-8. 2012
  6. pmc MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders
    Flora Tassone
    Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, California 95616, USA
    Autism Res 4:250-61. 2011
  7. pmc Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes
    Paul Ashwood
    Department of Medical Microbiology and Immunology, University of California at Davis, United States
    J Neuroimmunol 204:149-53. 2008
  8. doi request reprint Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study
    Roger S Akins
    Department of Pediatrics, School of Medicine, University of California, Davis, CA MIND Medical Investigation of Neurodevelopmental Disorders Institute, University of California, Davis, CA Department of Pediatrics, Naval Medical Center Portsmouth, Portsmouth, VA Divisions of Epidemiology and Environmental and Occupational Health, Department of Public Health Sciences, School of Medicine, University of California, Davis, CA
    J Dev Behav Pediatr 35:1-10. 2014
  9. doi request reprint Autism spectrum disorders in Hispanics and non-Hispanics
    Virginia Chaidez
    Department of Public Health Sciences, University of California, Davis, CA 95618, USA
    Autism 16:381-97. 2012
  10. doi request reprint Minor physical anomalies in children with autism spectrum disorders
    Kathleen Angkustsiri
    University of California, Davis, USA
    Autism 15:746-60. 2011

Collaborators

Detail Information

Publications18

  1. pmc Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study
    Paula E Goines
    Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, 451 Health Sciences Dr, Suite 6510, Davis, CA 95616, USA
    Mol Autism 2:13. 2011
    ..abstract:..
  2. pmc Polybrominated diphenyl ethers in relation to autism and developmental delay: a case-control study
    Irva Hertz-Picciotto
    Department of Public Health Sciences, School of Medicine, University of California, MS1C, One Shields Ave, Davis, California, USA
    Environ Health 10:1. 2011
    ..PBDEs and their metabolites cross the placenta and studies in rodents demonstrate neurodevelopmental toxicity from prenatal exposures. PBDE exposures occur both via breastfeeding and hand-to-mouth activities in small children...
  3. doi request reprint Regression in autism: prevalence and associated factors in the CHARGE Study
    Robin L Hansen
    Medical Investigation of Neurodevelopmental Disorders Institute, University of California, Davis, Sacramento 95817, USA
    Ambul Pediatr 8:25-31. 2008
    ..The aim of this study was to examine the prevalence of regressive autism and associated demographic, medical, and developmental factors by using 2 different definitions of regression based on the Autism Diagnostic Interview, Revised...
  4. pmc Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study
    Rebecca J Schmidt
    Department of Public Health Sciences, University of California Davis School of Medicine, Davis, CA 95616 8638, USA
    Am J Clin Nutr 96:80-9. 2012
    ..Periconceptional folate is essential for proper neurodevelopment...
  5. pmc Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders
    Paula Krakowiak
    Division of Epidemiology, Department of Public Health Sciences, University of California, Davis, California, USA
    Pediatrics 129:e1121-8. 2012
    ....
  6. pmc MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders
    Flora Tassone
    Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, California 95616, USA
    Autism Res 4:250-61. 2011
    ..19, 7.91, P = 0.02 for AU vs. TD, and OR = 3.26, 95% CI = 1.35, 7.89, P = 0.009 for AU+ASD vs. TD). These results suggest a potential role of the functional MAOA promoter alleles in the male child, the mother, or both in ASD...
  7. pmc Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes
    Paul Ashwood
    Department of Medical Microbiology and Immunology, University of California at Davis, United States
    J Neuroimmunol 204:149-53. 2008
    ..Such immune dysregulation may predispose to the development of possible autoimmune responses and/or adverse neuroimmune interactions during critical windows in development...
  8. doi request reprint Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study
    Roger S Akins
    Department of Pediatrics, School of Medicine, University of California, Davis, CA MIND Medical Investigation of Neurodevelopmental Disorders Institute, University of California, Davis, CA Department of Pediatrics, Naval Medical Center Portsmouth, Portsmouth, VA Divisions of Epidemiology and Environmental and Occupational Health, Department of Public Health Sciences, School of Medicine, University of California, Davis, CA
    J Dev Behav Pediatr 35:1-10. 2014
    ..To compare the utilization of conventional treatments and utilization of complementary and alternative medicine in preschoolers with autism spectrum disorders (ASD) and other developmental disabilities (DD)...
  9. doi request reprint Autism spectrum disorders in Hispanics and non-Hispanics
    Virginia Chaidez
    Department of Public Health Sciences, University of California, Davis, CA 95618, USA
    Autism 16:381-97. 2012
    ..To compare differences in autism between Hispanic and non-Hispanics. We also examined the relationship between multiple language exposure and language function and scores of children...
  10. doi request reprint Minor physical anomalies in children with autism spectrum disorders
    Kathleen Angkustsiri
    University of California, Davis, USA
    Autism 15:746-60. 2011
    ..This study employs an adaptation of Miles and Hillman's (2000) classifications by using photographs to identify a subgroup with significant dysmorphology among children with ASD, typical development (TYP), and developmental delay (DD)...
  11. doi request reprint Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study
    Paula Krakowiak
    Division of Epidemiology, Department of Public Health Sciences, School of Medicine, University of California, Davis, CA, USA
    J Sleep Res 17:197-206. 2008
    ..Factor scores for children with DD were intermediate between the ASD and TD groups. Cognitive or adaptive development did not predict severity of sleep problems in the ASD group...
  12. pmc Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study
    Ousseny Zerbo
    Department of Public Health Sciences, MS1C, University of California Davis, CA 95616, USA
    J Autism Dev Disord 43:25-33. 2013
    ..However, the fever-associated ASD risk was attenuated among mothers who reported taking antipyretic medications (OR = 1.30, 95 % CI 0.59, 2.84), but remained elevated for those who did not (OR = 2.55, 95 % CI 1.30, 4.99)...
  13. pmc Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism
    Rebecca J Schmidt
    Department of Public Health Sciences, University of California Davis School of Medicine, Davis, CA, USA
    Epidemiology 22:476-85. 2011
    ..Causes of autism are unknown. Associations with maternal nutritional factors and their interactions with gene variants have not been reported...
  14. pmc MECP2 promoter methylation and X chromosome inactivation in autism
    Raman P Nagarajan
    Medical Microbiology and Immunology and Rowe Program in Human Genetics, University of California, Davis, CA 95616, USA
    Autism Res 1:169-78. 2008
    ..These results suggest that the aberrant MECP2 methylation in autism brain DNA samples is due to locus-specific rather than global X chromosome methylation changes...
  15. pmc Increased anti-phospholipid antibodies in autism spectrum disorders
    Milo Careaga
    Department of Medical Microbiology and Immunology, University of California, Davis, USA MIND Institute, University of California, 2805 50th Street Sacramento, Davis, CA 95817, USA
    Mediators Inflamm 2013:935608. 2013
    ....
  16. doi request reprint Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families
    R Scott Akins
    The MIND Institute, Pediatrics, University of California, Davis, 2825 50th Street, Sacramento, California 95817, USA
    Neurotherapeutics 7:307-19. 2010
    ....
  17. ncbi request reprint Neurodevelopmental outcome at 8 months and 4 years among infants born full-term small-for-gestational-age
    Laura L Jelliffe-Pawlowski
    Department of Human and Community Development, University of California, Davis, Sacramento, CA, USA
    J Perinatol 24:505-14. 2004
    ..To examine the association between intrauterine growth restriction and neurodevelopmental outcome among full-term small-for-gestational-age (SGAT) infants at 8 months and 4 years of age...
  18. pmc Secretin and sleep in children with autism
    Ryan D Honomichl
    University of California, Davis 95616, USA
    Child Psychiatry Hum Dev 33:107-23. 2002
    ..Because of the small sample size, the results from both trials are preliminary. They suggest that secretin, porcine or synthetic, does not improve sleep-wake state organization dramatically...